Athenex to Provide Corporate and Financial Update for the Second Quarter 2021 on August 5, 2021

NEXT STORY
Innovation Pharmaceuticals Announces New In Vitro Data Supporting Brilacidin’s Broad-Spectrum Antiviral Potential Presented at the American Society of Virology’s Annual Meeting
PREV STORY
Antares Pharma Announces FDA Acceptance of IND Application for ATRS-1902 for Adrenal Crisis Rescue
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Vaxart Announces Additional Data from Hamster Challenge Study of its Oral COVID-19 Vaccine

author_avatar
NASDAQ Market News

Scopus BioPharma to Reschedule 2021 Annual Meeting of Shareholders

author_avatar
NASDAQ Market News

Viracta Initiates Treatment of First Patient in EBV+ Lymphoma Clinical Trial with Tractinostat

author_avatar
NASDAQ Market News